Alcon is canning 260 employees, half of them from the Dallas Ft. Worth area. The company said that sluggish U.S. drug sales and the recent launch by a rival company of a generic drug that competes directly with Tobradex treatment for eye infections are the reasons for the layoffs.

Let’s see what investor relations VP Doug MacHatton had to say:

“This is a difficult financial environment. It’s a difficult operating environment. The (U.S.) economy has had greater impact on patient dynamics – filling prescriptions, going to the doctor – than any other market in the world.”

What??!! No thanks for all the drug pushing? The freakin CEO didn’t even make a statement! It was the investor relations PR. Not cool Alcon, not cool indeed…

At least those laid off will get severance packages that include an additional two months on the payroll, a regular amount of payments based on their years of service, some extra cash to offset the price of health benefits and outplacement services.

Blah blah blah…

Image from proactod.com

Related Posts